Nippon Shinyaku Co., Ltd. 4516.T Stock
Nippon Shinyaku Co., Ltd. Price Chart
Nippon Shinyaku Co., Ltd. 4516.T Financial and Trading Overview
Nippon Shinyaku Co., Ltd. stock price | 4285 JPY |
Previous Close | 6378 JPY |
Open | 6373 JPY |
Bid | 6466 JPY x 0 |
Ask | 6482 JPY x 0 |
Day's Range | 6361 - 6514 JPY |
52 Week Range | 5260 - 8880 JPY |
Volume | 504K JPY |
Avg. Volume | 308.15K JPY |
Market Cap | 435.58B JPY |
Beta (5Y Monthly) | 0.146743 |
PE Ratio (TTM) | 17.594885 |
EPS (TTM) | 358.4 JPY |
Forward Dividend & Yield | 120 (1.84%) |
Ex-Dividend Date | September 28, 2023 |
1y Target Est | 9168.8 JPY |
4516.T Valuation Measures
Enterprise Value | 369.37B JPY |
Trailing P/E | 17.594885 |
Forward P/E | 14.609406 |
PEG Ratio (5 yr expected) | 2.27 |
Price/Sales (ttm) | 3.0211554 |
Price/Book (mrq) | 2.226561 |
Enterprise Value/Revenue | 2.562 |
Enterprise Value/EBITDA | 10.526 |
Trading Information
Nippon Shinyaku Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.146743 |
52-Week Change | -12.027% |
S&P500 52-Week Change | 20.43% |
52 Week High | 8880 JPY |
52 Week Low | 5260 JPY |
50-Day Moving Average | 6247.54 JPY |
200-Day Moving Average | 6949.19 JPY |
4516.T Share Statistics
Avg. Volume (3 month) | 308.15K JPY |
Avg. Daily Volume (10-Days) | 296.24K JPY |
Shares Outstanding | 67.35M |
Float | 67.25M |
Short Ratio | N/A |
% Held by Insiders | 5.10% |
% Held by Institutions | 48.01% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 114 |
Trailing Annual Dividend Yield | 1.78% |
5 Year Average Dividend Yield | 114.99% |
Payout Ratio | 0.3176 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 15.82% |
Operating Margin (ttm) | 20.84% |
Gross Margin | 61.17% |
EBITDA Margin | 24.33% |
Management Effectiveness
Return on Assets (ttm) | 8.21% |
Return on Equity (ttm) | 12.11% |
Income Statement
Revenue (ttm) | 144.18B JPY |
Revenue Per Share (ttm) | 2140.62 JPY |
Quarterly Revenue Growth (yoy) | 9.59% |
Gross Profit (ttm) | N/A |
EBITDA | 35.09B JPY |
Net Income Avi to Common (ttm) | 22.81B JPY |
Diluted EPS (ttm) | 367.55 |
Quarterly Earnings Growth (yoy) | -94.19% |
Balance Sheet
Total Cash (mrq) | 71.6B JPY |
Total Cash Per Share (mrq) | 1063.07 JPY |
Total Debt (mrq) | 2.66B JPY |
Total Debt/Equity (mrq) | 1.36 JPY |
Current Ratio (mrq) | 4.487 |
Book Value Per Share (mrq) | 2904.479 |
Cash Flow Statement
Operating Cash Flow (ttm) | 26.17B JPY |
Levered Free Cash Flow (ttm) | 12.85B JPY |
Profile of Nippon Shinyaku Co., Ltd.
Country | Japan |
State | N/A |
City | Kyoto |
Address | 14, Nishinosho-Monguchi-cho |
ZIP | 601-8550 |
Phone | 81 7 5321 1111 |
Website | https://www.nippon-shinyaku.co.jp |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, otorhinolaryngology, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva for humanized anti-CD20 monoclonal antibody; Defiterio sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. Nippon Shinyaku Co., Ltd.'s products also comprise Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler solution for allergic rhinitis; Azunol Gargle liquid, a gargling solution containing azulene; Isobide for oral osmotic diuresis/meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for cancer and chronic pain. Further, the company provides functional foods, such as health food ingredients, preservatives, protein preparations, and sports and aging care supplements. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
Q&A For Nippon Shinyaku Co., Ltd. Stock
What is a current 4516.T stock price?
Nippon Shinyaku Co., Ltd. 4516.T stock price today per share is 4285 JPY.
How to purchase Nippon Shinyaku Co., Ltd. stock?
You can buy 4516.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nippon Shinyaku Co., Ltd.?
The stock symbol or ticker of Nippon Shinyaku Co., Ltd. is 4516.T.
Which industry does the Nippon Shinyaku Co., Ltd. company belong to?
The Nippon Shinyaku Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Nippon Shinyaku Co., Ltd. have in circulation?
The max supply of Nippon Shinyaku Co., Ltd. shares is 67.35M.
What is Nippon Shinyaku Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Nippon Shinyaku Co., Ltd. PE Ratio is 11.95591500 now.
What was Nippon Shinyaku Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Nippon Shinyaku Co., Ltd. EPS is 358.4 JPY over the trailing 12 months.
Which sector does the Nippon Shinyaku Co., Ltd. company belong to?
The Nippon Shinyaku Co., Ltd. sector is Healthcare.
Nippon Shinyaku Co., Ltd. 4516.T included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nasdaq Developed Select Leaders NQDMSLC | 1260.81 USD — |
0
|
— — | 1243.71 USD — | 1264.94 USD — | — - | — — |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
- {{ link.label }} {{link}}